Pete De Spain | executive |
Troy Wilson | executive |
Thomas Doyle | executive |
Jonathan Chang | analyst |
Jason Zemansky | analyst |
Jiale Song | analyst |
Li Wang Watsek | analyst |
Bradley Canino | analyst |
Peter Lawson | analyst |
Reni Benjamin | analyst |
Justin Zelin | analyst |
George Farmer | analyst |
Good afternoon, ladies and gentlemen, and welcome to the Q1 2024 Kura Oncology Financial Results Conference Call. [Operator Instructions]. This call is being recorded on Thursday, May 2, 2024. I would now like to turn the conference over to Pete De Spain, Head of Investor Relations. Please go ahead.
Thanks, Chris.